Ontology highlight
ABSTRACT:
SUBMITTER: Ben-Ami E
PROVIDER: S-EPMC6094670 | biostudies-literature | 2016 Jun
REPOSITORIES: biostudies-literature
Melanoma management 20160525 2
The accelerated development in the treatment of metastatic melanoma, both in molecular targeted therapy and immunotherapy, is already starting to impact on adjuvant therapy in stage III melanoma. Following the approval of ipilimumab for adjuvant therapy in melanoma, clinical trials assessing other checkpoint modulators and MAPK pathway inhibitors as adjuvant treatments for melanoma are currently ongoing. As results from these trials mature in the next few years, a change in the landscape of adju ...[more]